HR
Price
$16.48
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
5.39B
38 days until earnings call
PSA
Price
$296.07
Change
-$1.63 (-0.55%)
Updated
Jan 17 closing price
Capitalization
50.96B
37 days until earnings call
Ad is loading...

HR vs PSA

Header iconHR vs PSA Comparison
Open Charts HR vs PSABanner chart's image
Healthcare Realty Trust
Price$16.48
Change-$0.00 (-0.00%)
Volume$1.39M
Capitalization5.39B
Public Storage
Price$296.07
Change-$1.63 (-0.55%)
Volume$587.34K
Capitalization50.96B
HR vs PSA Comparison Chart
Loading...
HR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HR vs. PSA commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HR is a Hold and PSA is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (HR: $16.48 vs. PSA: $296.07)
Brand notoriety: HR and PSA are both not notable
Both companies represent the Real Estate Investment Trusts industry
Current volume relative to the 65-day Moving Average: HR: 45% vs. PSA: 82%
Market capitalization -- HR: $5.39B vs. PSA: $50.96B
HR [@Real Estate Investment Trusts] is valued at $5.39B. PSA’s [@Real Estate Investment Trusts] market capitalization is $50.96B. The market cap for tickers in the [@Real Estate Investment Trusts] industry ranges from $243.79B to $0. The average market capitalization across the [@Real Estate Investment Trusts] industry is $5.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HR’s FA Score shows that 0 FA rating(s) are green whilePSA’s FA Score has 1 green FA rating(s).

  • HR’s FA Score: 0 green, 5 red.
  • PSA’s FA Score: 1 green, 4 red.
According to our system of comparison, PSA is a better buy in the long-term than HR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HR’s TA Score shows that 1 TA indicator(s) are bullish while PSA’s TA Score has 4 bullish TA indicator(s).

  • HR’s TA Score: 1 bullish, 2 bearish.
  • PSA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PSA is a better buy in the short-term than HR.

Price Growth

HR (@Real Estate Investment Trusts) experienced а +3.06% price change this week, while PSA (@Real Estate Investment Trusts) price change was +2.45% for the same time period.

The average weekly price growth across all stocks in the @Real Estate Investment Trusts industry was +2.35%. For the same industry, the average monthly price growth was -0.96%, and the average quarterly price growth was -1.98%.

Reported Earning Dates

HR is expected to report earnings on May 13, 2025.

PSA is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Real Estate Investment Trusts (+2.35% weekly)

A real estate investment trust (REIT) is a company any that owns, and in most cases, operates, income-producing real estate – ranging from office and apartment buildings to warehouses, hospitals, shopping centers, hotels and timberlands. Some REITs are involved in financing real estate. Equity REITs invest in and own properties, while mortgage REITs own and invest in property mortgages. REITs are required by law to pay out at least 90% of their annual taxable income (excluding capital gains) to shareholders in the form of dividends. Some REITs could be more cyclical than others; for example, when an economy is undergoing a recession, hotel REITs could be more vulnerable, compared to say healthcare REIT given that healthcare needs are less likely to depend on economic cycles. American Tower Corporation, Prologis, Inc. and Crown Castle International Corp are some of the biggest REIT companies in the U.S.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PSA($51B) has a higher market cap than HR($5.39B). HR has higher P/E ratio than PSA: HR (38.61) vs PSA (25.90). PSA YTD gains are higher at: -1.125 vs. HR (-2.773). PSA has higher annual earnings (EBITDA): 3.34B vs. HR (742M). PSA has more cash in the bank: 370M vs. HR (25.7M). HR has less debt than PSA: HR (5.3B) vs PSA (9.1B). PSA has higher revenues than HR: PSA (4.52B) vs HR (1.34B).
HRPSAHR / PSA
Capitalization5.39B51B11%
EBITDA742M3.34B22%
Gain YTD-2.773-1.125246%
P/E Ratio38.6125.90149%
Revenue1.34B4.52B30%
Total Cash25.7M370M7%
Total Debt5.3B9.1B58%
FUNDAMENTALS RATINGS
HR vs PSA: Fundamental Ratings
HR
PSA
OUTLOOK RATING
1..100
3716
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
91
Overvalued
PROFIT vs RISK RATING
1..100
10035
SMR RATING
1..100
9231
PRICE GROWTH RATING
1..100
5757
P/E GROWTH RATING
1..100
8135
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HR's Valuation (41) in the Real Estate Investment Trusts industry is somewhat better than the same rating for PSA (91). This means that HR’s stock grew somewhat faster than PSA’s over the last 12 months.

PSA's Profit vs Risk Rating (35) in the Real Estate Investment Trusts industry is somewhat better than the same rating for HR (100). This means that PSA’s stock grew somewhat faster than HR’s over the last 12 months.

PSA's SMR Rating (31) in the Real Estate Investment Trusts industry is somewhat better than the same rating for HR (92). This means that PSA’s stock grew somewhat faster than HR’s over the last 12 months.

PSA's Price Growth Rating (57) in the Real Estate Investment Trusts industry is in the same range as HR (57). This means that PSA’s stock grew similarly to HR’s over the last 12 months.

PSA's P/E Growth Rating (35) in the Real Estate Investment Trusts industry is somewhat better than the same rating for HR (81). This means that PSA’s stock grew somewhat faster than HR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HRPSA
RSI
ODDS (%)
N/A
Bullish Trend 11 days ago
88%
Stochastic
ODDS (%)
N/A
Bullish Trend 11 days ago
59%
Momentum
ODDS (%)
N/A
Bearish Trend 11 days ago
52%
MACD
ODDS (%)
N/A
Bullish Trend 11 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
61%
Bearish Trend 11 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
60%
Bearish Trend 11 days ago
54%
Advances
ODDS (%)
Bullish Trend 26 days ago
54%
Bullish Trend 24 days ago
62%
Declines
ODDS (%)
Bearish Trend 11 days ago
62%
Bearish Trend 20 days ago
56%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
64%
Bearish Trend 11 days ago
63%
View a ticker or compare two or three
Ad is loading...
HR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALRM61.36-0.02
-0.03%
Alarm.com Holdings
ILMN136.67-0.70
-0.51%
Illumina
MSEX51.06-0.47
-0.91%
Middlesex Water Company
BOLT0.51-0.01
-1.61%
Bolt Biotherapeutics
FDMT4.58-0.10
-2.14%
4D Molecular Therapeutics